Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Pigment Epithelium-Derived Factor (PEDF), also known as Serpin F1, is a multifunctional, secreted glycoprotein belonging to the non-inhibitory serpin family. It is a potent endogenous inhibitor of angiogenesis and exhibits neurotrophic and antitumor properties. PEDF is widely expressed across various tissues and organs and plays a role in retinal and neurodegenerative diseases, cancer, fibrosis, and metabolic syndrome. Its expression is regulated by sex steroids/hormones and TGF-beta signaling.
PEDF exerts its effects through multiple mechanisms, including promoting neuronal differentiation and survival, inhibiting angiogenesis by inducing endothelial cell apoptosis and suppressing proliferation, and modulating inflammation and fibrosis. The precise signaling pathways involved depend on the specific microenvironment and post-translational modifications.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Pigment Epithelium-Derived Factor (PEDF).